These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 29116404)
1. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids. Burke MF; Burke FM; Soffer DE Curr Atheroscler Rep; 2017 Nov; 19(12):60. PubMed ID: 29116404 [TBL] [Abstract][Full Text] [Related]
2. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study. Hobbs T; Caso R; McMahon D; Nymark M Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367 [TBL] [Abstract][Full Text] [Related]
3. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737 [TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story. Singh S; Arora RR; Singh M; Khosla S Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517 [TBL] [Abstract][Full Text] [Related]
5. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671 [TBL] [Abstract][Full Text] [Related]
6. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Sherratt SCR; Libby P; Budoff MJ; Bhatt DL; Mason RP Curr Atheroscler Rep; 2023 Jan; 25(1):1-17. PubMed ID: 36580204 [TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids and cardiovascular disease: new developments and applications. Harris WS; Dayspring TD; Moran TJ Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766 [TBL] [Abstract][Full Text] [Related]
11. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options. Weintraub H Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and omega-3s: Prescription products and fish oil dietary supplements are not the same. Gutstein AS; Copple T J Am Assoc Nurse Pract; 2017 Dec; 29(12):791-801. PubMed ID: 29280361 [TBL] [Abstract][Full Text] [Related]
13. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis. Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Oscarsson J; Hurt-Camejo E Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence. Bhat S; Sarkar S; Zaffar D; Dandona P; Kalyani RR Curr Cardiol Rep; 2023 Feb; 25(2):51-65. PubMed ID: 36729217 [TBL] [Abstract][Full Text] [Related]